Anti-PCSK9 antibodies for hypercholesterolaemia: Overview of clinical data and implications for primary care

Volume: 71, Issue: 8, Pages: e12979 - e12979
Published: Jul 27, 2017
Abstract
SummaryObjectives To put data from our recent systematic review of phase 3 studies of anti-proprotein convertase subtilisin/kexin type 9 (PCSK9) antibodies into the context of clinical practice. Methods Data from studies previously identified by a systematic review of phase 3 studies of alirocumab and evolocumab and additional references from non-systematic literature searches were used. We evaluated the hypothetical cardiovascular (CV)...
Paper Details
Title
Anti-PCSK9 antibodies for hypercholesterolaemia: Overview of clinical data and implications for primary care
Published Date
Jul 27, 2017
Volume
71
Issue
8
Pages
e12979 - e12979
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.